Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Influenza

Free Subscription 21.04.2025 6 Am J Med 1 BMC Pediatr 1 Epidemiol Infect 1 J Exp Med 1 J Immunol 10 J Infect Dis 8 J Virol 4 J Virol Methods 3 Minerva Pediatr (Torino) 1 PLoS Comput Biol 9 PLoS One 2 Proc Natl Acad Sci U S A 1 Vaccine 3 Virology 4 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Med

1. BILC M, Cramer H
   Use of Complementary Medicine Among US Adults with Post-COVID-19: Results from the 2022 National Health Interview Survey.
   Am J Med. 2025;138:862-869.
   PubMed         Abstract available
   
   
2. MAURO M, Cegolon L, Bestiaco N, Zulian E, et al
   Heart Rate Variability Modulation Through Slow-Paced Breathing in Health Care Workers with Long COVID: A Case-Control Study.
   Am J Med. 2025;138:870-883.
   PubMed         Abstract available
   
   
3. NAIK H, Wilton J, Tran KC, Janjua NZ, et al
   Long-Term Health-Related Quality of Life in Working-Age COVID-19 Survivors: A Cross-Sectional Study.
   Am J Med. 2025;138:850-861.
   PubMed         Abstract available
   
   
4. PALACIO A, Bast E, Klimas N, Tamariz L, et al
   Lessons Learned in Implementing a Multidisciplinary Long COVID Clinic.
   Am J Med. 2025;138:843-849.
   PubMed         Abstract available
   
   
5. KRUMHOLZ HM, Sawano M, Bhattacharjee B, Caraballo C, et al
   The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVID.
   Am J Med. 2024 May 10:S0002-9343(24)00271-7. doi: 10.1016/j.amjmed.2024.
   PubMed         Abstract available
   
   
6. SANAL-HAYES NEM, Hayes LD, Mclaughlin M, Berry ECJ, et al
   People with Long COVID and ME/CFS Exhibit Similarly Impaired Dexterity and Bimanual Coordination: A Case-Case-Control Study.
   Am J Med. 2025;138:893-900.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

7. SINAEI R, Hosseininasab A, Abbaslou P, Zeinali M, et al
   Gastrointestinal and hepatic manifestations among hospitalized COVID-19 children.
   BMC Pediatr. 2025;25:308.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

8. ABUCAR EAM, Kern M, Kurth T, Meierkord A, et al
   Health-related quality of life up to 2 years after SARS-CoV-2 infection: a descriptive cohort study.
   Epidemiol Infect. 2025;153:e60.
   PubMed         Abstract available
   
   

   
   J Exp Med

9. SAIDOUNE F, Lee D, Di Domizio J, Le Floc'h C, et al
   Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblains.
   J Exp Med. 2025;222:e20231467.
   PubMed         Abstract available
   
   

   
   J Immunol

10. MADRID DMC, Gu W, Karim SJI, Lowke MT, et al
    Single-cell analysis of pig lung leukocytes and their response to influenza infection and oseltamivir therapy.
    J Immunol. 2025 Apr 15:vkaf032. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Infect Dis

11. MORRIS SE, Mathis SM, Reeves E, Chung JR, et al
    Modeling the Potential Impacts of Outpatient Antiviral Treatment in Reducing Influenza-Associated Hospitalizations in the United States.
    J Infect Dis. 2025 Apr 12:jiaf061. doi: 10.1093.
    PubMed         Abstract available
    
    
12. CORTIER T, Gilboa M, Layan M, Joseph G, et al
    Factors Associated With the Transmission of the Delta Severe Acute Respiratory Syndrome Coronavirus 2 Variant in Households: The Israeli COVID-19 Family Study (ICoFS).
    J Infect Dis. 2025;231:e734-e742.
    PubMed         Abstract available
    
    
13. KOZANLI E, Winkel AMAM, Han AX, van den Brink S, et al
    Shortened SARS-CoV-2 Viral RNA Shedding in Saliva During Early Omicron Compared to Wild-Type Pandemic Phase.
    J Infect Dis. 2025;231:940-945.
    PubMed         Abstract available
    
    
14. CHALKIAS S, Pragalos A, Akinsola A, Berman G, et al
    Safety and Immunogenicity of SARS-CoV-2 Spike Receptor-Binding Domain andN-Terminal Domain mRNA Vaccine.
    J Infect Dis. 2025 Jan 10:jiaf022. doi: 10.1093.
    PubMed         Abstract available
    
    
15. FELDSTEIN LR, Ruffin J, Wiegand RE, Borkowf CB, et al
    Effectiveness of mRNA COVID-19 vaccines and hybrid immunity in preventing SARS-CoV-2 infection and symptomatic COVID-19 among adults in the United States.
    J Infect Dis. 2025 Jan 8:jiaf007. doi: 10.1093.
    PubMed         Abstract available
    
    
16. DOLANGE V, Slamanig S, Abdeljawad A, Lai TY, et al
    A Surrogate Enzyme-Linked Immunosorbent Assay to Select High-Titer Human Convalescent Plasma for Treating Immunocompromised Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern.
    J Infect Dis. 2025;231:e723-e733.
    PubMed         Abstract available
    
    
17. ALESSANDRINI J, Smith BT, Fitzpatrick T, Buchan SA, et al
    Socioeconomic Inequities in the Age-Specific Burden of Severe Respiratory Syncytial Virus in Canada, 2016-2019.
    J Infect Dis. 2025;231:e626-e637.
    PubMed         Abstract available
    
    
18. JACOBS MB, Clark AE, Goldhaber NH, Valentine HD, et al
    Antibody Levels From High-Throughput Variant-Specific SARS-CoV-2 Anti-Spike Immunoglobulin G and Angiotensin-Converting Enzyme 2 Neutralization Assays Correlate With COVID-19 Infection Risk in a Large Population.
    J Infect Dis. 2025;231:921-930.
    PubMed         Abstract available
    
    
19. SANKARANARAYANAN R, Ha B, Sun H, Liu K, et al
    Evaluation of Immunoglobulin A Enzyme Immunoassays to Detect Primary Respiratory Syncytial Virus Infection in Infants and Young Children.
    J Infect Dis. 2025;231:1060-1068.
    PubMed         Abstract available
    
    
20. CHO HK, Frivold C, Chu HY
    Maternal Immunization.
    J Infect Dis. 2025;231:830-836.
    PubMed         Abstract available
    
    

    
    J Virol

21. HU H, Zhang Y, Zheng H, Zhao X, et al
    Thymic stromal lymphopoietin improves protective immunity of the SARS-CoV-2 subunit vaccine by inducing dendritic cell-dependent germinal center response.
    J Virol. 2025 Mar 4:e0232324. doi: 10.1128/jvi.02323.
    PubMed         Abstract available
    
    
22. KARL V, Hofmann M, Thimme R
    Role of antiviral CD8+ T cell immunity to SARS-CoV-2 infection and vaccination.
    J Virol. 2025 Mar 3:e0135024. doi: 10.1128/jvi.01350.
    PubMed         Abstract available
    
    
23. LOWEN AC, Baker AL, Bowman AS, Garcia-Sastre A, et al
    Pandemic risk stemming from the bovine H5N1 outbreak: an account of the knowns and unknowns.
    J Virol. 2025;99:e0005225.
    PubMed         Abstract available
    
    
24. SIMS A, Weir DJ, Cole SJ, Hutchinson E, et al
    SARS-CoV-2 cellular coinfection is limited by superinfection exclusion.
    J Virol. 2025 Mar 21:e0207724. doi: 10.1128/jvi.02077.
    PubMed         Abstract available
    
    
25. DADONAITE B, Burrell AR, Logue J, Chu HY, et al
    SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals.
    J Virol. 2025 Mar 25:e0010925. doi: 10.1128/jvi.00109.
    PubMed         Abstract available
    
    
26. JOHN K, Huntress I, Smith E, Chou H, et al
    Human long noncoding RNA VILMIR is induced by major respiratory viral infections and modulates the host interferon response.
    J Virol. 2025 Mar 25:e0014125. doi: 10.1128/jvi.00141.
    PubMed         Abstract available
    
    
27. LI P, Faraone JN, Hsu CC, Chamblee M, et al
    Role of glycosylation mutations at the N-terminal domain of SARS-CoV-2 XEC variant in immune evasion, cell-cell fusion, and spike stability.
    J Virol. 2025 Mar 26:e0024225. doi: 10.1128/jvi.00242.
    PubMed         Abstract available
    
    
28. JANA ID, Kanjo K, Roy S, Bhasin M, et al
    Early 2022 breakthrough infection sera from India target the conserved cryptic class 5 epitope to counteract immune escape by SARS-CoV-2 variants.
    J Virol. 2025 Mar 26:e0005125. doi: 10.1128/jvi.00051.
    PubMed         Abstract available
    
    

    
    J Virol Methods

29. CHANG C, Li L, Guo Y, Ji L, et al
    The potential application of digital PCR in detecting different SARS-CoV-2 viral loads.
    J Virol Methods. 2025;335:115151.
    PubMed         Abstract available
    
    
30. DE BEER C, Vanmali HD
    Genotypic analysis of rhinovirus and human respiratory syncytial virus in sudden unexpected death in infancy cases at Tygerberg Hospital, Cape Town, South Africa.
    J Virol Methods. 2025;335:115150.
    PubMed         Abstract available
    
    
31. ZARGAR B, Sattar SA, McKinney J, Ijaz MK, et al
    The stability and elimination of mammalian enveloped and non-enveloped respiratory and enteric viruses in indoor air: Testing using a room-sized aerobiology chamber.
    J Virol Methods. 2025;335:115144.
    PubMed         Abstract available
    
    
32. REYNA RA, Walker J, Viveros A, Mitchell B, et al
    Optimization of a panel of behavioral tests for use in containment using a golden Syrian hamster model.
    J Virol Methods. 2025;335:115132.
    PubMed         Abstract available
    
    

    
    Minerva Pediatr (Torino)

33. PECORARO L, Castagnoli R, Salemi C, Piacentini G, et al
    The "stay at home" COVID-19 lockdown restriction may have prevented asthma exacerbations in children affected by pollen allergy: a single center experience.
    Minerva Pediatr (Torino). 2025;77:139-142.
    PubMed         Abstract available
    
    
34. SODERO G, Talloa D, Cipolla C
    GH therapy in children and adolescents with growth hormone deficiency during the first phase of COVID-19 lockdown: a survey in an Italian center.
    Minerva Pediatr (Torino). 2025;77:148-153.
    PubMed         Abstract available
    
    
35. TESARI CRNKOVIC H, Bendelja K, Gjergja Juraski R, Turkalj M, et al
    Respiratory syncytial virus specific immunoglobulin G4 antibodies and atopic diseases in children.
    Minerva Pediatr (Torino). 2025;77:130-138.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

36. POZZATI G, Flores SC
    Combining flipped-classroom and spaced-repetition learning in a master-level bioinformatics course.
    PLoS Comput Biol. 2025;21:e1012863.
    PubMed         Abstract available
    
    

    
    PLoS One

37. IWU CD, Shrestha P, Littman AJ, Hood JE, et al
    The association between healthcare access and shingles vaccination among older adults in Virginia, United States.
    PLoS One. 2025;20:e0316429.
    PubMed         Abstract available
    
    
38. STRICKLING M, Zarif N, Nguyen H, Moradi Khalaj S, et al
    A comparison of fit, heat stress, oxygen saturation and comfort between a novel reusable mask and disposable N95 respirator.
    PLoS One. 2025;20:e0321538.
    PubMed         Abstract available
    
    
39. AGUIRRE-MILACHAY E, Leon-Figueroa DA, Diaz-Velez C, Valladares-Garrido MJ, et al
    Factors associated with the survival of adults with COVID-19 using a high-flow nasal cannula in a tertiary hospital in northern Peru during the second wave of the pandemic.
    PLoS One. 2025;20:e0309855.
    PubMed         Abstract available
    
    
40. VILLOTA SD, Veloz-Villavicencio E, Garcia-Iturralde S, Arevalo JV, et al
    Validation of new equipment for SARS-CoV-2 diagnosis in Ecuador: Detection of the virus and antibodies generated by disease and vaccines with one POC device.
    PLoS One. 2025;20:e0321794.
    PubMed         Abstract available
    
    
41. PARKINSON C, Shen X, MacDonald M, Logan SW, et al
    Outdoor recreation's association with mental health and well-being during the COVID-19 pandemic.
    PLoS One. 2025;20:e0321278.
    PubMed         Abstract available
    
    
42. SUSLOW A, Schlossler K, Chikhradze N, Lauer R, et al
    Should I stay or should I go-Medical assistants experiences and coping with patient demand and lack of appreciation during the Covid-19 pandemic.
    PLoS One. 2025;20:e0320953.
    PubMed         Abstract available
    
    
43. LEISER R, McLeod J, Mapp F, Stirrup O, et al
    Insights into the implementation of a whole genome sequencing report form (SRF) to reduce nosocomial SARS-CoV-2 in UK hospitals within an unfolding pandemic: A qualitative process evaluation using normalisation process theory.
    PLoS One. 2025;20:e0321534.
    PubMed         Abstract available
    
    
44. CILOVIC-LAGARIJA S, Eitze S, Skocibusic S, Musa S, et al
    Behavioral insights during the COVID-19 pandemic in the Federation of Bosnia and Herzegovina: the role of trust, health literacy, risk and fairness perceptions in compliance with public health and social measures.
    PLoS One. 2025;20:e0320433.
    PubMed         Abstract available
    
    
45. QUINTERO-RINCON A, Di-Pasquale R, Quintero-Rodriguez K, Batatia H, et al
    Computer-based quantitative image texture analysis using multi-collinearity diagnosis in chest X-ray images.
    PLoS One. 2025;20:e0320706.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

46. RIOS CARRASCO M, Lin TH, Zhu X, Gabarroca Garcia A, et al
    The Q226L mutation can convert a highly pathogenic H5 2.3.4.4e virus to bind human-type receptors.
    Proc Natl Acad Sci U S A. 2025;122:e2419800122.
    PubMed         Abstract available
    
    
47. HUANG QJ, Kim R, Song K, Grigorieff N, et al
    Virion-associated influenza hemagglutinin clusters upon sialic acid binding visualized by cryoelectron tomography.
    Proc Natl Acad Sci U S A. 2025;122:e2426427122.
    PubMed         Abstract available
    
    

    
    Vaccine

48. TONG F, Zhou T, Tang L, Wu X, et al
    Evaluating the impact of influenza vaccine on preventing stroke hospitalization and death in Chinese elderly hypertensive patients: A retrospective cohort study.
    Vaccine. 2025;54:127004.
    PubMed         Abstract available
    
    

    
    Virology

49. BEAUDOIN-BUSSIERES G, Tauzin A, Dionne K, El Ferri O, et al
    Multiple exposures to SARS-CoV-2 Spike enhance cross-reactive antibody-dependent cellular cytotoxicity against SARS-CoV-1.
    Virology. 2025;607:110512.
    PubMed         Abstract available
    
    
50. ANDERSON M, Lopez J, Wyr M, Ramirez PW, et al
    Defining diverse spike-receptor interactions involved in SARS-CoV-2 entry: Mechanisms and therapeutic opportunities.
    Virology. 2025;607:110507.
    PubMed         Abstract available
    
    
51. CHAKRABORTY C, Bhattacharya M, Abdelhameed AS
    Recent SARS-CoV-2 evolution trajectories indicate the emergence of Omicron's several subvariants and the current rise of KP.3.1.1 and XEC.
    Virology. 2025;607:110508.
    PubMed         Abstract available
    
    

    
    Virus Res

52. ZHAO X, Zhu X, Wang J, Ye C, et al
    The epidemiological analysis of respiratory virus infections in Children in Hangzhou from 2019 to 2023.
    Virus Res. 2025;355:199558.
    PubMed         Abstract available
    
    
53. ZADEH VR, Lew JM, Zahoor MA, Santer D, et al
    Combination therapy enhances the antiviral activity of IFN-lambda against SARS-CoV-2 and MERS-CoV.
    Virus Res. 2025;355:199560.
    PubMed         Abstract available
    
    
54. YAN J, Liu F, Hu S, Pan J, et al
    Regional dynamics and mechanisms behind SARS-CoV-2 XDV.1 prevalence in Chongqing via genomic surveillance and molecular insights.
    Virus Res. 2025;355:199562.
    PubMed         Abstract available
    
    
55. YANG W, Tao T, Zhang J, Yao Y, et al
    The association of cycle threshold value with clinical features in patients infected with Omicron variant.
    Virus Res. 2025;355:199565.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.